ESCOTOMAS DEFINICION PDF

Los profesionales de la visión realizan las pruebas del campo visual para detectar puntos ciegos (escotomas) y otros defectos del campo visual, que pueden. Transcript of Definición. Anatomía Sintomatología Actuación de la Tiamina y tratamiento. Diagnóstico Definición Síntomas: Otras: Técnicas. deza visual, visión borrosa, fotopsias, escotomas y amaurosis transitorias o definitivas; al igual que la función de estructuras relacionadas como los mús-.

Author: Mezishakar Kigis
Country: Poland
Language: English (Spanish)
Genre: Video
Published (Last): 16 October 2005
Pages: 414
PDF File Size: 15.1 Mb
ePub File Size: 15.52 Mb
ISBN: 183-5-32163-839-7
Downloads: 41926
Price: Free* [*Free Regsitration Required]
Uploader: Sak

Guidelines of clinical practice of the SERV: Treatment of exudative age-related macular degeneration AMD. Hospital Universitari de Bellvitge. Hospital La Paz Madrid. Hospital Provincial de Conxo Santiago de Compostela.

Age related macular degeneration ARMD in its neovascular form is a serious disease which produces legal blindness in many patients with poor prognosis if left untreated. We intend to establish a clinical guide with the different therapeutic options that exist nowadays, which may help escotkmas ophthalmologists in their clinical practice.

A group of medical retina experts selected by SERV have evaluated the results of different published studies definiccion the drugs currently available, obtaining an evidence-based consensus.

Migrañas oculares (o migrañas oftálmicas)

Some recommendations have been established for diagnosis, treatment and monitoring of patients with neovascular ARMD. The intravitreal injection of ranibizumab at a dosage of 0. It should be considered as a first choice drug. The use of bevacizumab, a drug with not approved indication for intraocular use, nor for the treatment of neovascular ARMD can reach a result which is closer to the ones obtained with ranibizumab definifion to those obtained with photodynamic therapy PDT and pegaptanib.

The use of intravitreal pegaptanib sodium in devinicion injection at a eacotomas of 0. The results of the evidence-based studies are a good guide for the treatment of this disease Arch Soc Esp Oftalmol ; Algoritmos de manejo de la DMAE. Debe establecerse con enfermedades que cursen con drusas o con aquellas que producen atrofias del complejo EPRcoriocapilar.

  IMMEDIATE FICTION JERRY CLEAVER PDF

Por ello, se aconseja tratamiento con vitaminas antioxidantes vitamina E, C y betacarotenos y suplementos minerales zinc. Enfermedad neovascular que comienza siendo intrarretiniana, para extenderse al espacio subretiniano y establecer anastomosis retinocoroidea.

Hemorragia vítrea | Surgicare of Wichita

Dilataciones vasculares polipoideas en defijicion coroides que se asocian a cuadros repetidos de sangrado subretiniano. Es la prueba por excelencia para el estudio de la DMAE exudativa. Entre ellas, cabe destacar: Sin embargo, debe considerarse la posibilidad de no ser necesario recurrir a las tres dosis, a juicio del especialista, ante situaciones que lo justifiquen.

Para ello, la rejilla de Amsler puede ser de utilidad. Macular photocoagulation study group. Argon laser photocoagulation for neovascular maculopathy. Five-years results from randomized clinical trials.

Arch Ophthalmol ; Argon laser photocoagulation for juxtafoveal choroidal neovascularization. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration.

Results of a randomized clinical trials. Krypton laser photocoagulation of peripapillary choroidal neovascular membrane. Ophthalmic Surg Lasers ; Laser photocoagulation of indocyanine green aniographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol ; Focal laser ablation of retinal angiomatous proliferation. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.

Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Kokame GT, Yamaoka S. Subretinal surgery for peripapillary subretinal neovascular membranes.

Exámenes del campo visual para el glaucoma y otros problemas oculares

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Photodynamic therapy and high doses intravitreal triamcinolone to treat exudative age-related macular degeneration: Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: Invest Ophthalmol Vis Sci ; Evolving European guidance on the medical management of neovascular age related macular degeneration.

Br J Ophthalmol ; Pegaptanib for neovascular age-related macular degeneration. N Engl J Med ; Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration FOCUS: Ranibizumab for neovascular age-related macular degeneration.

  CNET CSH-2400 PDF

Ranibizumab versus verteporfin for neovascular age-related macular degeneration. Antivascular endothelial growth factor agents and their development: The vascular endothelial growth factor proteins: Growth Factors ; 7: Selection and analysis of an optimized anti-VEGF antibody: J Mol Biol ; Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.

Lucentis at one year. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: Systemic bevacizumab Avastin therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Optical coherence tomography findings after an intravitreal injection of bevacizumab Avastin for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging ; Optical coherence tomography findings after an intravitreal injection of bevacizumab Avastin for neovascular age-related macular degeneration.

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Intravitreal bevacizumab Avastin for occult choroidal neovascularization in age-related macular degeneration.

Graefes Arch Clin Exp Ophthalmol ; Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration.

Short-term safety and efficacy of intravitreal bevacizumab Avastin for neovascular age-related macular degeneration. Intravitreal bevacizumab Avastin treatment of neovascular age-related macular degeneration. Intravitreal bevacizumab in the treatment of neovascular agerelated macular degeneration, 6- and 9-month results. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: Intravitreal bevacizumab Avastin for neovascular age-related macular degeneration: Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration.

Update findings from two clinical trials. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab Lucentis for neovascular age-related macular degeneration. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.

Membranas ocultas que han cobrado identidad propia: